The identification and resistance analysis to 66 strains of corynebacterium clinical isolates

LI Wei,ZHANG Zheng
2007-01-01
Abstract:Objective Due to less reports about corynebacterium clinical isolates in China,this study was conducted to understand the distribution,infection status and resistance pattern to antibacterials in China.66 strains of corynebacterium clinical isolates since 2000 were identified and analyzed.Methods 66 strains of corynebacterium isolates were identified with API Coryne System(BioMerieux,France) and MICs were determined by the agar dilution method.Results C.striatum was the most common isolates 42(63.6 %),next were C.aquaticum 5(7.6 %),C.ANF group 4(6 %),C.minutissimum 4(6 %)et al.The main source of 66 isolates was Bronchofibroscope Secretion 36(54.5%),next was Blood 16(24.2%).66 isolates had Cefuroxime,Ceftazidime,Cefepime,Erythromycin,Azithromycin,Tetracycline,Clindamycin,Ciprifloxacin,Levofloxacin, Nitrofurantcin MIC90 s≥128 μg/mL and Sulphamethoxazole/trimethopim MIC90s>256/4864 μg/mL.66 isolates had Cefazolin,Penicillin,Ampicillin,Chloromycetin,Gentamicin,Amikacin,Minocycline MIC90s 16-64 μg/mL and Vancomycin MIC90 0.5 μg/mL.Conclusions C.striatum was most common of corynebacterium clinical isolates.Most of the patients were of immunocompromised crowd.Vancomycin was the most active antimicrobial agent against all.
What problem does this paper attempt to address?